Related Experiment Video

Updated: Nov 5, 2025

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

36.5K

CLIPPERS: A Treatable Cause of Spastic Ataxia

David P Breen1, Sapna Rawal2, Elizabeth J Slow1

  • 1Edmond J Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic Toronto Western Hospital Toronto Canada.

Movement Disorders Clinical Practice
|May 17, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CLIPPERSchronic lymphocytic inflammation with pontine perivascular enhacement responsive to steroidsneuroinflammationspastic ataxia

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.5K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.8K

Related Experiment Videos

Last Updated: Nov 5, 2025

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

36.5K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.5K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.8K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

631
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
631

Articles linked to this work by shared authors, journal, and citation graph.

Challenges in the diagnosis and management of functional movement disorders in a developing nation: insights from the Philippines.

Journal of neural transmission (Vienna, Austria : 1996)·2026

A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism.

Nature medicine·2026

Training strategies for neck ultrasound examination and ultrasound-guided cervical lymph node biopsies: a narrative review.

BMC medical education·2026

CSF α-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps.

Neurology·2026

Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study.

Neurology·2025

Comparative Analysis of L-Dopa and Deep Brain Stimulation on Bradykinesia Components in Parkinson's Disease.

Movement disorders clinical practice·2026

Multi-Domain Gait Profiling in Idiopathic Normal Pressure Hydrocephalus: Differentiating Fall Patterns and Assessing Shunt Responsiveness.

Movement disorders clinical practice·2026

DYT-PRKRA Dystonia-Parkinsonism with Pathological Startle: Expanding the Phenotype of PRKRA-Related Disease.

Movement disorders clinical practice·2026

Anti-Amphiphysin Stiff-Person Spectrum Disorders: A Systematic Review and Case Series Featuring an Unusual Isolated Upper-Limb Presentation.

Movement disorders clinical practice·2026

Exercise and Motor Complications in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Movement disorders clinical practice·2026

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Movement disorders clinical practice·2026

Three-Dimensional Optical and Computational Reconstruction of Colloidal Electrokinetic Flows via Multiplane Imaging and Multiscale Modeling.

Small (Weinheim an der Bergstrasse, Germany)·2026

Effects of atmospheric cold plasma voltage on the interfacial properties of soy protein isolate-sodium alginate nanoemulsions co-loaded with curcumin and resveratrol and their application in surimi gels during chilled storage.

Food research international (Ottawa, Ont.)·2026

Systematic characterizations of a urinary protein, prosaposin, as a novel inhibitor of calcium oxalate stone formation.

International journal of biological macromolecules·2026

Atomic force microscopy (AFM) investigation of nanoscale bubble-microplastic interactions under varying ionic strength: Insights from extended DLVO theory.

Micron (Oxford, England : 1993)·2026

Development of endothelial injury under chemical hypoxia: early migration impairment precedes cytotoxicity in CoCl2-treated EA.hy926 cells.

Molecular biology reports·2026

Uptake of 14CO3 2- by HCP (CEM III/C and CEM III/C + CaCO3) in the presence and absence of ISA and chloride.

RSC advances·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us